Two new compounds may be able to treat retinitis pigmentosa, a group of inherited eye diseases that cause blindness. The compounds, described in a study published January 14 in the open-access ...

The discovery of this mechanism was unexpected. We suspect it may also explain why retinal cells in retinitis pigmentosa patients die. Defective splicing variants might also play a role in the ...

This mechanism of action not only preserves ... making them safer for long-term use. Retinitis pigmentosa affects over 100,000 people in the United States alone, with no approved treatments ...

Two new compounds may be able to treat retinitis pigmentosa, a group of inherited eye diseases that cause blindness. The compounds were identified using a virtual screening approach.

Two new compounds may be able to treat retinitis pigmentosa, a group of inherited eye diseases that cause blindness. The compounds, described in a study published January 14 th in the open-access ...

Scientists have identified two non-retinoid compounds that may be able to treat retinitis pigmentosa (RP), a group of inherited eye diseases that cause blindness. The compounds were discovered by ...

Considering taking supplements to treat retinitis pigmentosa? Below is a list of common natural remedies used to treat or reduce the symptoms of retinitis pigmentosa. Follow the links to read ...

Two-year data with eyeDNA Therapeutics’ gene therapy for retinitis pigmentosa (RP), an inherited form of blindness, has prompted the biotech to seek discussions with regulators about the design ...

In retinitis pigmentosa, a common eye disease that affects ... while the placebo group’s retinas thinned.” The potential mechanism explaining these results had been explored in a mouse study ...

Nanoscope Therapeutics is on the brink of filing for FDA approval of what could be the first gene therapy for incurable eye disease retinitis pigmentosa (RP) that can be used regardless of ...

Ocugen (OCGN) announced that the European Commission has provided a positive opinion from the EMA’s, or European Medicines Agency’s, Committee ...

Two new compounds may be able to treat retinitis pigmentosa, a group of inherited eye diseases that cause blindness. The compounds, described in a study published January 14 in the open-access ...